Morbidity in giant omphaloceles: Predictive factors and management strategies
Acta Paediatrica · 2024-12 · 113 (12) · 2504-2512
DOI: 10.1111/apa.17387 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Acta Paediatrica, online erschienen am 08.08.2024. Verfasst von Laura Martou und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatric Surgery, Chelsea Children's Hospital, Chelsea and Westminster NHS Foundation trust, Imperial College London, London, UK. Hauptthemen laut MEDLINE: Hernia, Umbilical. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Aim
To identify predictors of morbidity in GO through an analysis of associated anomalies, defect characteristics and management strategies.
Methods
PubMed and Ovid EMBASE databases were searched from 2013 to 2023. Primary end points assessed correlation of morbidity with gestational age (GA), birth weight (BW), eviscerated organs, defect size, associated anomalies and management strategy.
Results
Twenty articles were included for analysis with a total of 1009 GO. Median GA was 37 weeks (27–41), with a median BW of 2700 g (900–6000). 143 cardiovascular anomalies, 238 pulmonary anomalies, 98 musculoskeletal anomalies, 53 urogenital anomalies, 94 gastrointestinal anomalies, 11 neurological anomalies and 43 chromosomal anomalies were identified. 82 had unspecified additional anomalies, of which 20 and 17 were defined as major and minor, respectively. 123 neonates were managed with primary closure, 206 neonates with staged closure and 312 neonates with conservative treatment. Complications included sepsis, respiratory compromise, feeding dysfunction and closure‐related adverse events. Long‐term morbidity included home ventilation ( n = 72), long‐term parental nutrition ( n = 36), and delayed motor neurodevelopment ( n = 21). Main predictors of morbidity were pulmonary hypertension/hypoplasia, major congenital anomalies, greater defect size and liver herniation.
Conclusion
Key predictors of poor outcomes include the presence of additional congenital anomalies, defect size, liver herniation and pulmonary hypertension/hypoplasia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Paediatric Surgery, Chelsea Children's Hospital, Chelsea and Westminster NHS Foundation trust, Imperial College London, London, UK.
ORCID-Profile: Laura Martou
Zitieren
APA
Martou, L., & Saxena, A. K. (2024). Morbidity in giant omphaloceles: Predictive factors and management strategies. Acta Paediatrica, 113(12), 2504-2512. https://doi.org/10.1111/apa.17387
Vancouver
Martou L, Saxena AK. Morbidity in giant omphaloceles: Predictive factors and management strategies. Acta Paediatrica. 2024;113(12):2504-2512. doi:10.1111/apa.17387
BibTeX
@article{Martou2024,
author = {Martou, Laura and Saxena, Amulya K},
title = {Morbidity in giant omphaloceles: Predictive factors and management strategies},
journal = {Acta Paediatrica},
year = {2024},
volume = {113},
number = {12},
pages = {2504--2512},
doi = {10.1111/apa.17387}
}
EUVIMED